| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | -0.39 | 0.04 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | -0.26 | 0.1 |
| mRNA | paclitaxel | FIMM | pan-cancer | AAC | -0.25 | 0.08 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.22 | 0.2 |
| mRNA | Epothilone B | FIMM | pan-cancer | AAC | -0.21 | 0.3 |
| mRNA | 17-AAG | FIMM | pan-cancer | AAC | -0.14 | 0.5 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.14 | 0.002 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.13 | 0.004 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.13 | 0.006 |
| mRNA | Bryostatin 1 | FIMM | pan-cancer | AAC | -0.12 | 0.4 |